Is Biotech Back?
US biotech stocks overall have fared better than the broader US market, but with significant volatility. Still, the biotech IPO pipeline is picking up steam.
US biotech stocks overall have fared better than the broader US market, but with significant volatility. Still, the biotech IPO pipeline is picking up steam.
